Fifth Third Bancorp Neogenomics Inc Transaction History
Fifth Third Bancorp
- $28.3 Billion
- Q2 2025
A detailed history of Fifth Third Bancorp transactions in Neogenomics Inc stock. As of the latest transaction made, Fifth Third Bancorp holds 2,829 shares of NEO stock, worth $22,858. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,829
Previous 2,822
0.25%
Holding current value
$22,858
Previous $26,000
23.08%
% of portfolio
0.0%
Previous 0.0%
Shares
30 transactions
Others Institutions Holding NEO
# of Institutions
308Shares Held
129MCall Options Held
1.17MPut Options Held
297K-
Black Rock Inc. New York, NY19.7MShares$159 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.1MShares$114 Million0.0% of portfolio
-
Greenhouse Funds Lllp Baltimore, MD7.43MShares$60 Million2.32% of portfolio
-
First Light Asset Management, LLC Edina, MN6.85MShares$55.3 Million7.69% of portfolio
-
State Street Corp Boston, MA5.11MShares$41.3 Million0.0% of portfolio
About NEOGENOMICS INC
- Ticker NEO
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 125,796,000
- Market Cap $1.02B
- Description
- NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...